Packaged foods · Consumer Defensive · Fiscal year ends Dec 27
Pilgrims Pride reported revenue of $18.5B in the fiscal year ended Dec 2025, up 3.5% from the year before. Operating income was $1.6B, an operating margin of 8.7%, and net income was $1.1B. Operating cash flow of $1.4B less capital expenditure of $719M left free cash flow of $653M. Net debt was $2.5B.
Ranks among the 21 packaged foods companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 14,777 | 17,468 | 17,362 | 17,878 | 18,498 |
| Cost of revenue | 13,412 | 15,657 | 16,244 | 15,566 | 16,139 |
| Gross profit | 1,366 | 1,812 | 1,118 | 2,313 | 2,358 |
| Research & development | 5.1 | 12.5 | 5.7 | 12.4 | 17.9 |
| Selling, general & admin | 1,149 | 605 | 552 | 713 | 713 |
| Operating income | 211 | 1,177 | 522 | 1,506 | 1,614 |
| Interest expense | 146 | 153 | 202 | 161 | 161 |
| Pre-tax income | 92.4 | 1,025 | 365 | 1,412 | 1,502 |
| Income tax | 61.1 | 279 | 42.9 | 325 | 419 |
| Net income | 31.0 | 746 | 322 | 1,086 | 1,082 |
| Diluted EPS | 0.13 | 3.10 | 1.36 | 4.57 | 4.54 |
| Diluted shares | 244 | 240 | 237 | 238 | 238 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 428 | 401 | 698 | 2,041 | 640 |
| Receivables | 1,013 | 1,097 | 1,129 | 1,004 | 1,165 |
| Inventory | 1,576 | 1,990 | 1,985 | 1,783 | 2,031 |
| Current assets | 3,306 | 3,892 | 4,204 | 5,120 | 4,237 |
| Net PP&E | 2,918 | 2,941 | 3,158 | 3,138 | 3,533 |
| Goodwill | 1,337 | 1,228 | 1,286 | 1,239 | 1,339 |
| Total assets | 8,913 | 9,256 | 9,810 | 10,651 | 10,344 |
| Payables | 1,378 | 1,588 | 1,295 | 1,269 | 1,400 |
| Deferred revenue | 22.3 | 34.5 | 85.0 | 48.9 | 37.6 |
| Current liabilities | 2,391 | 2,570 | 2,496 | 2,552 | 2,890 |
| Short-term debt | 26.2 | 26.3 | 0.7 | 0.9 | 0.9 |
| Long-term debt | 3,191 | 3,166 | 3,341 | 3,206 | 3,093 |
| Total liabilities | 6,324 | 6,402 | 6,466 | 6,397 | 6,650 |
| Shareholders' equity | 2,577 | 2,841 | 3,331 | 4,239 | 3,680 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 326 | 670 | 678 | 1,990 | 1,372 |
| Capital expenditure | 382 | 487 | 558 | 459 | 719 |
| Free cash flow | −55.2 | 183 | 120 | 1,532 | 653 |
| Depreciation & amortisation | 381 | 403 | 420 | 434 | 456 |
| Stock-based compensation | 11.7 | 7.0 | 7.2 | 14.9 | 29.4 |
| Acquisitions | 967 | 9.7 | 0.0 | 0.0 | – |
| Dividends paid | – | – | 0.0 | 0.0 | 1,994 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 18.2% | −0.6% | 3.0% | 3.5% |
| Operating income growth (YoY) | – | 457.2% | −55.6% | 188.4% | 7.1% |
| EPS growth (YoY) | – | 2284.6% | −56.1% | 236.0% | −0.7% |
| Gross margin | 9.2% | 10.4% | 6.4% | 12.9% | 12.7% |
| Operating margin | 1.4% | 6.7% | 3.0% | 8.4% | 8.7% |
| Net margin | 0.2% | 4.3% | 1.9% | 6.1% | 5.9% |
| Return on equityBlank when equity is negative | 1.2% | 26.3% | 9.7% | 25.6% | 29.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 3.2% | 17.6% | 7.1% | 18.6% | 21.6% |
| Free cash flow margin | −0.4% | 1.0% | 0.7% | 8.6% | 3.5% |
| Cash conversion (CFO ÷ net income) | 10.5x | 0.90x | 2.11x | 1.83x | 1.27x |
| Receivable days | 25 | 23 | 24 | 21 | 23 |
| Inventory days | 43 | 46 | 45 | 42 | 46 |
| Payable days | 38 | 37 | 29 | 30 | 32 |
| Interest cover | 1.45x | 7.71x | 2.58x | 9.34x | 10.00x |
| Debt ÷ equity | 1.25x | 1.12x | 1.00x | 0.76x | 0.84x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 2,790 | 2,792 | 2,644 | 1,166 | 2,454 |
| Current ratio | 1.38x | 1.51x | 1.68x | 2.01x | 1.47x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.